Veno-Occlusive Disease (Sinusoidal Obstruction Syndrome)
What is Veno-Occlusive Disease (Sinusoidal Obstruction Syndrome)?
Veno-occlusive disease, also called sinusoidal obstruction syndrome, is a serious liver complication. It happens when small blood vessels inside the liver become blocked. This blockage stops blood from flowing properly through the liver.
The condition most often occurs after stem cell transplants or high-dose chemotherapy. These treatments can damage the delicate lining of liver blood vessels. When the vessels swell and narrow, blood backs up in the liver. This causes the liver to enlarge and stops it from working normally.
Veno-occlusive disease typically develops within the first month after transplant or chemotherapy. Early detection through blood testing is critical for better outcomes. Without treatment, the condition can progress to liver failure and life-threatening complications.
Symptoms
Symptoms of veno-occlusive disease usually appear suddenly within 1 to 3 weeks after transplant or chemotherapy. Common signs include:
- Yellowing of the skin and eyes, called jaundice
- Sudden weight gain from fluid buildup
- Swollen and tender abdomen
- Enlarged liver that can be felt during examination
- Fluid accumulation in the belly, called ascites
- Pain in the upper right side of the abdomen
- Dark urine and pale stools
- Confusion or mental changes in severe cases
Some people have mild symptoms at first that worsen quickly. Others develop severe symptoms within days. The severity often depends on how much liver damage has occurred.
Concerned about Veno-Occlusive Disease (Sinusoidal Obstruction Syndrome)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Veno-occlusive disease is caused by damage to the inner lining of small liver blood vessels. High-dose chemotherapy drugs and radiation therapy used before bone marrow or stem cell transplants are the most common triggers. These treatments injure the delicate cells lining the vessels. This damage causes inflammation, swelling, and eventually blockage of blood flow.
Risk factors include conditioning regimens with certain chemotherapy drugs, total body radiation, prior liver disease, and genetic factors. Younger children and people receiving second transplants face higher risk. Some herbal supplements and medications can also damage liver vessels and increase risk.
How it's diagnosed
Doctors diagnose veno-occlusive disease using a combination of symptoms, physical exam, and blood tests. Blood work typically shows elevated bilirubin, a yellow pigment that builds up when the liver cannot process it properly. Rite Aid offers bilirubin testing as part of our flagship panel. Rising bilirubin levels are a key diagnostic marker and help monitor disease severity.
Imaging tests like ultrasound can show liver enlargement and fluid buildup. Liver biopsy may be needed in unclear cases but carries risks. Diagnosis often relies on clinical criteria including jaundice, weight gain, enlarged liver, and elevated bilirubin within weeks of transplant or chemotherapy. Early testing helps catch the condition before serious complications develop.
Treatment options
- Supportive care including fluid management and pain control
- Defibrotide, a medication that protects blood vessel lining and improves blood flow
- Careful monitoring of fluid balance and kidney function
- Diuretics to reduce fluid buildup when appropriate
- Avoiding medications that can further damage the liver
- Treatment of complications like kidney problems or bleeding
- In severe cases, consideration of liver transplant
- Nutritional support and low-sodium diet to manage fluid retention
Treatment works best when started early, before severe liver damage occurs. Most people with mild to moderate disease recover with proper care. Severe cases require intensive monitoring in specialized transplant centers. Regular blood testing helps doctors track recovery and adjust treatment as needed.
Concerned about Veno-Occlusive Disease (Sinusoidal Obstruction Syndrome)? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Veno-occlusive disease is a liver condition where small blood vessels inside the liver become blocked. It usually happens after stem cell transplants or high-dose chemotherapy. The blockage prevents blood from flowing properly through the liver, causing it to enlarge and stop working normally.
People receiving stem cell or bone marrow transplants are at highest risk, especially those getting high-dose chemotherapy or total body radiation beforehand. Other risk factors include prior liver disease, certain chemotherapy drugs, young age, and second transplants. Some herbal supplements can also increase risk.
The first signs usually appear within 1 to 3 weeks after transplant or chemotherapy. They include sudden weight gain, jaundice with yellowing of skin and eyes, tender and swollen abdomen, and pain under the right ribs. Dark urine and an enlarged liver are also common early signs.
Diagnosis combines symptoms, physical exam findings, and blood tests. Elevated bilirubin levels are a key marker that shows the liver cannot process waste properly. Doctors also look for weight gain, liver enlargement, and fluid buildup within weeks of transplant. Imaging tests and sometimes liver biopsy help confirm the diagnosis.
Yes, blood tests measuring bilirubin are critical for detecting and monitoring veno-occlusive disease. Bilirubin rises when liver blood vessels become blocked and the liver cannot function properly. Regular testing after transplant or chemotherapy helps catch the condition early. Rite Aid offers bilirubin testing to monitor liver health.
Treatment includes supportive care like fluid management and a medication called defibrotide that protects blood vessels. Doctors carefully monitor kidney function and use diuretics when needed to reduce fluid buildup. Most people with mild to moderate disease recover with proper care. Severe cases may require intensive monitoring or liver transplant.
Prevention focuses on reducing risk before transplant or chemotherapy. This includes using lower-intensity conditioning regimens when possible and avoiding liver-toxic medications. Some centers use preventive defibrotide in high-risk patients. Screening for existing liver problems before transplant also helps identify those who need closer monitoring.
Veno-occlusive disease can be life-threatening if severe or left untreated. Mild cases often resolve with supportive care and medication. Severe cases can lead to liver failure, kidney problems, and bleeding complications. Early detection through blood testing and prompt treatment significantly improve survival rates.
Recovery time varies based on severity. Mild cases may improve within weeks with proper treatment. Moderate cases can take several months to fully resolve. Severe cases require longer recovery and intensive medical care. Regular blood tests help doctors track healing and determine when liver function returns to normal.
Yes, regular bilirubin testing is important after stem cell transplant or high-dose chemotherapy. Rising bilirubin levels can signal veno-occlusive disease developing. Testing every few days during the first month helps catch problems early. Early detection allows for faster treatment and better outcomes.